Targeting metabolism as a novel therapeutic approach to autoimmunity, inflammation, and transplantation

Ian A. Bettencourt, Jonathan D. Powell

Research output: Contribution to journalReview article

Abstract

Immune cell activation and differentiation occurs concurrently with metabolic reprogramming. This ensures that activated cells generate the energy and substrates necessary to perform their specified function. Likewise, the metabolic programs among different cells of the immune system vary. By targeting different metabolic pathways, these differences allow for selective regulation of immune responses. Further, the relative susceptibility of cells to a metabolic inhibitor is dictated by their metabolic demands; cellular selectivity is based on demand. Therefore, where differences exist in metabolic pathways between healthy and pathogenic cells, there is opportunity for selective regulation with agents lacking intrinsic specificity. There are now a host of studies demonstrating how inhibitors of metabolism (e.g., glycolysis, glutamine metabolism, and fatty acid oxidation) can regulate immune responses and treat immune-mediated pathogenesis. In this brief review we detail how inhibitors of metabolism can be employed to regulate immune responses in both autoimmunity and transplantation.

Original languageEnglish (US)
Pages (from-to)999-1005
Number of pages7
JournalJournal of Immunology
Volume198
Issue number3
DOIs
StatePublished - Feb 1 2017

Fingerprint

Autoimmunity
Transplantation
Inflammation
Metabolic Networks and Pathways
Glycolysis
Glutamine
Cell Differentiation
Immune System
Fatty Acids

ASJC Scopus subject areas

  • Immunology

Cite this

Targeting metabolism as a novel therapeutic approach to autoimmunity, inflammation, and transplantation. / Bettencourt, Ian A.; Powell, Jonathan D.

In: Journal of Immunology, Vol. 198, No. 3, 01.02.2017, p. 999-1005.

Research output: Contribution to journalReview article

Bettencourt, Ian A.; Powell, Jonathan D. / Targeting metabolism as a novel therapeutic approach to autoimmunity, inflammation, and transplantation.

In: Journal of Immunology, Vol. 198, No. 3, 01.02.2017, p. 999-1005.

Research output: Contribution to journalReview article

@article{3331f068579146f7885eae7458fde378,
title = "Targeting metabolism as a novel therapeutic approach to autoimmunity, inflammation, and transplantation",
abstract = "Immune cell activation and differentiation occurs concurrently with metabolic reprogramming. This ensures that activated cells generate the energy and substrates necessary to perform their specified function. Likewise, the metabolic programs among different cells of the immune system vary. By targeting different metabolic pathways, these differences allow for selective regulation of immune responses. Further, the relative susceptibility of cells to a metabolic inhibitor is dictated by their metabolic demands; cellular selectivity is based on demand. Therefore, where differences exist in metabolic pathways between healthy and pathogenic cells, there is opportunity for selective regulation with agents lacking intrinsic specificity. There are now a host of studies demonstrating how inhibitors of metabolism (e.g., glycolysis, glutamine metabolism, and fatty acid oxidation) can regulate immune responses and treat immune-mediated pathogenesis. In this brief review we detail how inhibitors of metabolism can be employed to regulate immune responses in both autoimmunity and transplantation.",
author = "Bettencourt, {Ian A.} and Powell, {Jonathan D.}",
year = "2017",
month = "2",
doi = "10.4049/jimmunol.1601318",
volume = "198",
pages = "999--1005",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Targeting metabolism as a novel therapeutic approach to autoimmunity, inflammation, and transplantation

AU - Bettencourt,Ian A.

AU - Powell,Jonathan D.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Immune cell activation and differentiation occurs concurrently with metabolic reprogramming. This ensures that activated cells generate the energy and substrates necessary to perform their specified function. Likewise, the metabolic programs among different cells of the immune system vary. By targeting different metabolic pathways, these differences allow for selective regulation of immune responses. Further, the relative susceptibility of cells to a metabolic inhibitor is dictated by their metabolic demands; cellular selectivity is based on demand. Therefore, where differences exist in metabolic pathways between healthy and pathogenic cells, there is opportunity for selective regulation with agents lacking intrinsic specificity. There are now a host of studies demonstrating how inhibitors of metabolism (e.g., glycolysis, glutamine metabolism, and fatty acid oxidation) can regulate immune responses and treat immune-mediated pathogenesis. In this brief review we detail how inhibitors of metabolism can be employed to regulate immune responses in both autoimmunity and transplantation.

AB - Immune cell activation and differentiation occurs concurrently with metabolic reprogramming. This ensures that activated cells generate the energy and substrates necessary to perform their specified function. Likewise, the metabolic programs among different cells of the immune system vary. By targeting different metabolic pathways, these differences allow for selective regulation of immune responses. Further, the relative susceptibility of cells to a metabolic inhibitor is dictated by their metabolic demands; cellular selectivity is based on demand. Therefore, where differences exist in metabolic pathways between healthy and pathogenic cells, there is opportunity for selective regulation with agents lacking intrinsic specificity. There are now a host of studies demonstrating how inhibitors of metabolism (e.g., glycolysis, glutamine metabolism, and fatty acid oxidation) can regulate immune responses and treat immune-mediated pathogenesis. In this brief review we detail how inhibitors of metabolism can be employed to regulate immune responses in both autoimmunity and transplantation.

UR - http://www.scopus.com/inward/record.url?scp=85014605811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014605811&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1601318

DO - 10.4049/jimmunol.1601318

M3 - Review article

VL - 198

SP - 999

EP - 1005

JO - Journal of Immunology

T2 - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -